The Cancer Biology Training Grant (CBTG) at the University of Minnesota provides rigorous laboratory-based training in the biology of cancer so that trainees can establish themselves as independent investigators who will pursue research into the etiology and treatment of cancer. The CBTG has been funded by the NCI since 1975, and is the foundation of the educational mission of the University of Minnesota NCI-designated Comprehensive Cancer Center. The 37 CBTG preceptors are Cancer Center members and perform cutting edge research in the areas of cell growth, metastasis &angiogenesis, immunology &cancer, cancer genetics and cancer therapy. The CBTG Director, Dr. Yoji Shimizu, and members of the CBTG Steering Committee hold leadership positions within the Cancer Center and have established track records in training of future scientists. During the past funding period, an increased focus on cancer research resulted in the designation of a specific interdisciplinary Ph.D. graduate program in cancer biology at the University of Minnesota. Dr. Shimizu is the Director of this program, which allows him to identify and recruit the most highly qualified trainees to the CBTG. New, coordinated recruiting in molecular and cellular biology, and the addition of a graduate feeder program in Pharmacology, have further improved the quality of the trainee pool. The CBTG Director also works directly with CBTG preceptors to identify and recruit highly qualified postdoctoral trainees to CBTG laboratories. We have also worked to recruit trainees from under-represented groups. During the last funding period, 19% of the trainees supported on the CBTG were from these groups. Trainees are selected on a competitive basis by the CBTG Steering Committee using clearly defined criteria. All trainees participate in a training program that includes a semester-long course in cancer biology, a weekly Cancer Biology Research Club meeting where trainees present their latest research in progress, a weekly Cancer Center seminar series where trainees select, invite and host an external speaker, interaction with clinicians who provide insights into the realities of cancer patient treatment and care, and career development workshops sponsored by the University of Minnesota's Office of Postdoctoral Affairs. Thus, the CBTG fosters the career development of the most outstanding predoctoral and postdoctoral trainees possible so that they can pursue independent research careers in cancer biology.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Institutional National Research Service Award (T32)
Project #
3T32CA009138-35S2
Application #
7938527
Study Section
Subcommittee G - Education (NCI)
Program Officer
Aguila, H Nelson
Project Start
2009-09-30
Project End
2011-09-29
Budget Start
2009-09-30
Budget End
2011-09-29
Support Year
35
Fiscal Year
2009
Total Cost
$79,065
Indirect Cost
Name
University of Minnesota Twin Cities
Department
Pathology
Type
Schools of Medicine
DUNS #
555917996
City
Minneapolis
State
MN
Country
United States
Zip Code
55455
Gartlan, Kate H; Bommiasamy, Hemamalini; Paz, Katelyn et al. (2018) A critical role for donor-derived IL-22 in cutaneous chronic GVHD. Am J Transplant 18:810-820
Salzwedel, Amanda O; Han, Joohee; LaRocca, Christopher J et al. (2018) Combination of interferon-expressing oncolytic adenovirus with chemotherapy and radiation is highly synergistic in hamster model of pancreatic cancer. Oncotarget 9:18041-18052
Murphy, Katherine A; James, Britnie R; Sjaastad, Frances V et al. (2018) Cutting Edge: Elevated Leptin during Diet-Induced Obesity Reduces the Efficacy of Tumor Immunotherapy. J Immunol 201:1837-1841
Yang, Rendong; Van Etten, Jamie L; Dehm, Scott M (2018) Indel detection from DNA and RNA sequencing data with transIndel. BMC Genomics 19:270
Bohn, Jennifer A; Van Etten, Jamie L; Schagat, Trista L et al. (2018) Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins. Nucleic Acids Res 46:362-386
Du, Jing; Flynn, Ryan; Paz, Katelyn et al. (2018) Murine chronic graft-versus-host disease proteome profiling discovers CCL15 as a novel biomarker in patients. Blood 131:1743-1754
Regan Anderson, Tarah M; Ma, Shihong; Perez Kerkvliet, Carlos et al. (2018) Taxol Induces Brk-dependent Prosurvival Phenotypes in TNBC Cells through an AhR/GR/HIF-driven Signaling Axis. Mol Cancer Res 16:1761-1772
Jensen, Isaac J; Sjaastad, Frances V; Griffith, Thomas S et al. (2018) Sepsis-Induced T Cell Immunoparalysis: The Ins and Outs of Impaired T Cell Immunity. J Immunol 200:1543-1553
Leehy, Katherine A; Truong, Thu H; Mauro, Laura J et al. (2018) Progesterone receptors (PR) mediate STAT actions: PR and prolactin receptor signaling crosstalk in breast cancer models. J Steroid Biochem Mol Biol 176:88-93
Mooneyham, Ashley; Iizuka, Yoshie; Yang, Qing et al. (2018) UNC-45A Is a Novel Microtubule-Associated Protein and Regulator of Paclitaxel Sensitivity in Ovarian Cancer Cells. Mol Cancer Res :

Showing the most recent 10 out of 270 publications